ICUI · NASDAQ · STOCK
ICU Medical, Inc.
$181.87
52W $107.50 – $192.85
48/100
$4.55B
151.7
0.75
Is ICUI Bullish or Bearish?
Mixed.
Innellis AI committee rates ICU Medical, Inc. (ICUI) Watch with a composite score of 48/100
, based on 6 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +12.04 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -7.96 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -10.9% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.20 across 18 articles, 14d) — News
Bear Case
- P/E of 99.6 is expensive by classic value standards — Value
- ROE of only 2.2% -- cheap may mean cheap for a reason — Value
- Revenue declining -10.9% YoY -- this is not a growth story right now — Growth
- RSI at 73 is in overbought territory — Technical
- Weekly RSI at 83 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 21.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
48/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 97%
of 192 Healthcare peers
Value Analyst
bearish
35
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 99.6 is expensive by classic value standards
Growth Analyst
bearish
15
/ 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Revenue declining -10.9% YoY -- this is not a growth story right now
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 73 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 21.6% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 18 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
72.5
Overbought
MACD Histogram
1.262
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Bollinger %B
0.94
Inside Bands
Price vs Moving Averages
EMA 9
$174.37
Above
EMA 21
$166.98
Above
EMA 50
$155.97
Above
EMA 200
$142.55
Above
Fundamental Analysis
Valuation
64
Profitability
13
Financial Health
98
Cash Flow
70
Valuation
P/E Ratio
151.7×
P/B Ratio
2.12×
PEG Ratio
0.01
Dividend Yield
0.00%
52W High
$192.85
52W Low
$107.50
Quality & Growth
ROE
3.5%
ROA
1.8%
Gross Margin
3756.5%
Operating Margin
503.7%
Revenue Growth YoY
—
Debt / Equity
0.60
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 151.7 (rich relative to a 15-40x range); Price-to-book of 2.1x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.0%; Return on assets of 0.0%; Net margin of 1.4%; Gross margin of 37.6%; Current ratio of 2.43 (healthy short-term liquidity); Debt-to-equity of 0.60; Free cash flow per share is positive (6.11); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full ICUI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →